Some forms of FTD can have nonspecific increased tau and phospho-tau levels in CSF, but beta amyloid protein generally remains within the normal range, distinguishing the typical AD signature, with low beta amyloid CSF concentration.18 Primary mental disorders do not usually present marked changes in neuroimaging or CSF biomarkers. The gene discussed is MAPT; the disease is Alzheimer disease.